-
Leveraging Learning Systems to Improve Quality and Patient Safety in Allergen Immunotherapy Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-12 Alexandra E Conway BA, Chase Rupprecht DO, Priya Bansal MD, Irene Yuan MD, Ziwei Wang MD, Marcus S Shaker MD MS, Marylee Verdi, Joel Bradley MD
Adverse events occur in all fields of medicine including allergy-immunology, where allergen immunotherapy medical errors can result in significant harm. Though difficult to experience, such errors constitute opportunities for improvement. Identification of system vulnerabilities can allow resolution of latent errors before they become active problems. We review key aspects and frameworks of the medical
-
Associations between cord blood acetaminophen biomarkers and childhood asthma with and without allergic comorbidities Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-12 Yijun Li PhD, Xiumei Hong PhD, Aruna Chandran MD, Corinne A. Keet MD PhD, Clary B. Clish PhD, Liming Liang PhD, Lisa P. Jacobson ScD, Xiaobin Wang MD ScD, Christine Ladd-Acosta PhD
Previous studies have linked prenatal acetaminophen use to increased asthma risk in children. However, none have explored this association while differentiating between asthma cases with and without other allergic conditions or by employing objective biomarkers to assess acetaminophen exposure. Examine whether the detection of acetaminophen biomarkers in cord blood is associated with the subgroups
-
Undercooked Wheat Allergy and New Wheat Allergens - A Case Report Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-11 Ana Luísa Pinhal MD, Borja Bartolomé PhD, Diana Silva MD PhD
-
Who are the potential patients for Omalizumab for Food Allergy? Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-11 Hugh A. Sampson MD, J. Andrew Bird MD, David Fleischer MD, Wayne G. Shreffler MD PhD, Jonathan Spergel MD PhD
-
Real-world safety experience with Peanut (Arachis hypogaea) Allergen Powder-dnfp in 2,500 peanut-allergic children Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-11 Michele Jara DScMPH, Ekaterina Walker MD, Stephen Tilles MD, Aikaterini Anagnostou MDPhD
-
Contribution of caregiver and child anxiety and depressive symptoms to child asthma-related quality of life Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-06 Do Young Gwak MD, Juliann C. Tea MD, Fariya N. Fatima BS, Jayme M. Palka PhD, Heather Lehman MD, David A. Khan MD, Hannah Zhou XX, Beatrice L. Wood PhD, Bruce D. Miller MD, E. Sherwood Brown MD PhD
Depression and anxiety negatively affect asthma-related quality of life (QoL). Yet, little is known regarding mood and asthma-related factors that best uniquely explain asthma-related QoL in children. This cross-sectional study evaluated the unique variance explained by caregiver and child depressive and anxiety symptom severity in child asthma-related QoL, apart from that explained by demographics
-
The association of milk and multiple food avoidance with growth parameters in infants and children Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-04 Cansin Sackesen MD, Betul Buyuktiryaki MD, Tugba Gokce MSc, Emre Gogebakan MD, Beliz Su Gundogdu MD, Sevgi Bilgic Eltan MD, Elif Karakoc-Aydiner MD, Ebru Arik Yilmaz MD, Ceren Can MD, Hilal Cengiz MD, Ozlem Unlugedik MD, Nevin Celik MD, Said Incir MD, Gul Yesiltepe Mutlu MD, Damla Yildirim MSc, Hulya Gokmen Ozel MSc, Sukru Hatun MD
Recent studies reported that strict avoidance of milk products in cow's milk allergy (CMA) affects growth and bone turnover, causing negative calcium balance and changes in bone metabolism. To investigate biochemical parameters to predict bone turnover and its relations with height and weight measurements and nutritional intake. Height, weight, and body mass index z scores were plotted for age according
-
Eicosanoids, innate immunity, and alarmins in aspirin-exacerbated respiratory disease Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-01 Alexandra E. Conway BA, Andrew A. White MD, Larry Borish MD, Marcus Shaker MD MS, Michael W. Lee PhD
-
Safety and Efficacy Not Guaranteed: Separating Fact from Fiction Regarding Extensively Heated Egg and Milk Products: Separating fact from fiction regarding extensively heated egg and milk products Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-01 Aikaterini Anagnostou MD PhD, Matthew Greenhawt MD MBA MSc
-
Managing the packing list for college when it includes subcutaneous allergen immunotherapy Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-26 Marcus S. Shaker MD MS, Harold Kim MD, Jedidiah A. Peterson RN, Michael Tsoulis MD MS, Dana Wallace MD
-
Effect of the Israel-Hamas war on allergy and immunology care and research Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-25 Alon Y. Hershko MD PhD, Francesca Levi-Schaffer PharmD PhD
-
Plasma microRNAs as biomarkers in hereditary angioedema Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-25 Timothy Craig DO, Kristina Richwine BS, Faoud T. Ishmael MD PhD
Hereditary angioedema (HAE) is an autosomal dominant disease with variable expression. In some families with identical genetic abnormalities, the expression can range from several attacks per month to no attacks at all. It is hypothesized that post-transcriptional gene regulation accounts for the variable expression of the disease. To identify candidate microRNAs (miRNAs) that could play a role in
-
What lessons are learned?: Our changing practice during 30 years of hereditary angioedema treatment Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-23 Sevdenur Keskin MD, Yosif Pak DO, Jocelyn Celestin MD
-
What should be the outcome of biological treatment in asthma: "Remission on Treatment" or "Super-responder" Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-23 Gülden Paçacı Çetin, İnsu Yılmaz
-
Lower paraspinal muscle density is associated with small airway dysfunction in women with persistent asthma Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-23 Rory Chan, Chary Duraikannu, Mohamed Jaushal Thouseef, Brian Lipworth
-
Establishment of fluorescence multi-flow cytometric immunoassay for the simultaneous quantitative detection of six allergen-sIgE antibodies Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-23 Yuanmin Sun, Yixian Li, Jian Hu, Xiaohui Yang, Bei Zhang, Xueyan Wang, Huiqiang Li, Yang Yu
The in vitro specific IgE (sIgE) assays now commonly used in clinical laboratories are not only time-consuming and expensive, but also require a large number of serum samples. To address these limitations, a novel fluorescent microsphere-based multiplex flow cytometric immunoassay was developed. This innovative assay enables rapid and simultaneous quantitative detection of multiple allergen-sIgE antibodies
-
Proteomic and metabolomic proof of concept for unified airways in chronic rhinosinusitis and asthma Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-20 Yao Yao MS, Yujuan Yang MD, Jianwei Wang MD, Pengyi Yu BS, Jing Guo MD, Luchao Dong BS, Cai Wang BS, Pengfei Liu PhD, Yu Zhang MD PhD, Xicheng Song MD PhD
The pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP) with comorbid asthma remains unclear. To assess upper and lower airway unity and identify a possible common pathogenesis in CRSwNP with asthma. This study analyzed the expression of proteins and metabolites in nasal lavage fluid cells (NLFCs) and induced sputum cells (ISCs). Differentially expressed proteins and their function-related
-
Assessing Meaningful Change in the Asthma Impairment and Risk Questionnaire Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-17 William McCann, Kevin R. Murphy, Robert S. Zeiger, David A. Beuther, Robert A. Wise, Joan Reibman, Maureen George, Ileen Gilbert, James M. Eudicone, Hitesh N. Gandhi, Katelyn Cutts, Karin S. Coyne, Bradley Chipps
The Asthma Impairment and Risk Questionnaire (AIRQ) is a 10-item, yes/no, equally weighted control tool. Lower scores indicate better control. Seven impairment items reflect prior 2-week symptoms, and three risk items assess prior 12-month exacerbations. The Follow-up AIRQ for use between annual assessments has a 3-month recall period for exacerbation items. To evaluate the responsiveness of the AIRQ
-
Preparing Adolescents for Independent Asthma Management: Gaps and Opportunities Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-17 Suzanne Y. Ngo, Samantha Bothwell, John T. Brinton, William C. Anderson
-
Managing Anaphylaxis Away from Home Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-17 Theresa A. Bingemann, Marcus Shaker, Gena Heng, Matthew Greenhawt
-
Early solid introduction to prevent IgE-mediated food allergy should continue unabated while we learn more about FPIES prevalence Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-17 Linlei Ye, Stephanie C. Erdle, Elissa M. Abrams, Edmond S. Chan
-
Constant Vigilance! Managing Threats to the Skin Barrier Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-13 Vanessa Chu, Peck Y. Ong
Skin barrier defects are one of the primary causes of atopic dermatitis (AD). The basis of skin barrier defects in AD is due to a deficiency in various barrier proteins including filaggrin, involucrin, claudins, and lipids including ceramide, fatty acids and cholesterol. This review updates a more detailed lipid dysregulation in the skin barrier of AD based on recent lipidomic analysis. The clinical
-
Improved small airway dysfunction in severe asthma with clinical remission by anti-IL-5/IL-5 receptor α Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-13 Taisuke Akamatsu, Toshihiro Shirai, Kohei Okawa, Keita Hirai
-
Incidence of drug-induced hypersensitivity syndrome associated with levetiracetam and clobazam is likely underreported Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-10 Nikhita R. Kichili, Alyssa Hansen, Dheeraj Kagithala, Ayezel Munoz Gonzalez, Michael Wilkerson
-
Hereditary angioedema with normal C1-inhibitor: Clinical and genetic characterization of 15 Portuguese unrelated families Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-09 Eunice Dias de Castro MD PhD, Ana Luísa Pinhal MD, Mariana Bragança MD, João Parente Freixo MD, António Martinho MD
Hereditary angioedema with normal C1-inhibitor (HAE-nC1-INH) is a rare genetic disease with similar phenotype to HAE-C1-INH but different genetic background. Currently, 6 subtypes are recognized, based on the underlying mutations. Several aspects need further clarification. To assess clinical features of patients with genetically characterized HAE-nC1-INH from the North of Portugal. Retrospective assessment
-
Intrinsic risk factors for alpha-gal syndrome in a case-control study, 2019 to 2020 Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-08 Marissa L. Taylor, Gilbert J. Kersh, Johanna S. Salzer, Emma S. Jones, Alison M. Binder, Paige A. Armstrong, Shailesh K. Choudhary, Grace K. Commins, Claire L. Amelio, Brad J. Biggerstaff, Charles B. Beard, Lyle R. Petersen, Scott P. Commins
Alpha-gal syndrome (AGS) is an allergy to galactose-α-1,3-galactose (alpha-gal), a carbohydrate found in most mammals. Evidence indicates that AGS develops following a tick bite, and in the United States, AGS is most associated with bites from Amblyomma americanum (lone star tick); however, not all persons bitten by ticks develop clinical AGS. This study investigated intrinsic risk factors associated
-
Social vulnerability index, poverty, and asthma in a prospective study of Puerto Rican youth Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-06 Yueh-Ying Han, Franziska J. Rosser, Edna Acosta-Pérez, Glorisa Canino, Juan C. Celedón
Abstract not available
-
Predominantly antibody deficiency and the association with celiac disease in Sweden Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-06 Daniel V. DiGiacomo, Bjorn Roelstraete, Benjamin Lebwohl, Peter H.R. Green, Lennart Hammarström, Jocelyn R. Farmer, Hamed Khalili, Jonas F. Ludvigsson
Predominantly antibody deficiency (PAD) is associated with noninfectious inflammatory gastrointestinal disease. Population estimates of celiac disease (CeD) risk in those with PAD are limited. To estimate population risk of PAD in individuals with CeD. We conducted a nationwide case-control study in Swedish individuals who received a diagnosis of CeD between 1997 and 2017 (n = 34,980), matched to population
-
From the pages of AllergyWatch Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-03 Stanley Fineman, Gerald B. Lee, Samantha Knox, Iris Otani
Abstract not available
-
A pathogenic role for innate-like B cells in type 2 chronic rhinosinusitis with nasal polyps Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-01 Paul H. Dell
Abstract not available
-
A dedicated pathway to appropriate penicillin allergy examinations in pregnancy Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-01 Allison Ramsey
Abstract not available
-
-
Evolving atopic dermatitis toward precision medicine Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-01 Donald Y.M. Leung
Abstract not available
-
Information for Readers Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-01
Abstract not available
-
Table of Contents Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-01
Abstract not available
-
Toward a much-needed coming of age Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-01 Delphine Giusti, Jeanne-Marie Perotin, Joana Vitte
Abstract not available
-
Antiallergic/adrenergic drugs from 80 years ago: Still relevant today? Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-01 Marco Zurlo, Anna Nowak-Węgrzyn, Francesca Levi-Schaffer
Abstract not available
-
Popliteal Pioneers Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-01 Erin L. Reigh
Abstract not available
-
Response to “Managing Anaphylaxis - Epinephrine, Antihistamines, and Corticosteroids: Over 10 years of C-CARE Registry Data” Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-01 Eric Scheier
Abstract not available
-
Innovations in the treatment of anaphylaxis: A review of recent data Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-01 Thomas B. Casale, Anne K. Ellis, Sarina Tanimoto
Abstract not available
-
From the Pages of AllergyWatch Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-01-29 Stanley Fineman, Shyam R. Joshi, Iris Otani, Samantha Knox
Abstract not available
-
Food Allergies on a College Campus Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-01-29 Irene H Yuan, Matthew Greenhawt, Elissa M Abrams, Edwin H Kim, S Shahzad Mustafa, Edward G A Iglesia
There are limited data on food allergies among college students. In this article we review the most current available studies. These self-reported surveys and qualitative interviews report overall poor avoidance of known allergens and low rates of carrying self-injectable epinephrine (SIE) among food-allergic students. College students may exhibit risk-taking food behaviors due to a number of factors
-
Serologic Measurements for Peanut Allergy: Predicting Clinical Severity is Complex Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-01-24 Alexandra E Conway, David B.K. Golden, Helen A. Brough, Alexandra F Santos, Marcus S Shaker
Allergist-immunologists use serologic peanut allergy testing to maximize test sensitivity and specificity while minimizing cost and inconvenience. Recent advances towards this goal include a better understanding of specific IgE (sIgE) and component testing, epitope-sIgE assay, and basophil activation testing. Predicting reaction severity with serologic testing is challenged by a range of co-factors
-
Melatonin inhibits mast cell activation, indicating its potential as a therapeutic agent in inflammatory diseases. Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-01-20 Haozhen Ye, Peilin Cheng, Bingjie Jin, Hongwei Xu, Ben Wang
Abstract not available
-
Effect of Air Pollution on Asthma Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-01-20 Xiaoying Zhou, Vanitha Sampath, Kari C Nadeau
Asthma is a chronic inflammatory airway disease characterized by respiratory symptoms, variable airflow obstruction, bronchial hyperresponsiveness, and airway inflammation. Exposure to air pollution has been linked to an increased risk of asthma development and exacerbation. This review aims to comprehensively summarize recent data on the impact of air pollution on asthma development and exacerbation
-
Skin as the Target for Allergy Prevention and Treatment Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-01-20 Andreina Marques-Mejias, Irene Bartha, Christina E. Ciaccio, R. Sharon Chinthrajah, Susan Chan, Gurjit K. Khurana Hershey, Jessica W. Hui-Beckman, Laurie Kost, Gideon Lack, Janice A. Layhadi, Donald Y.M. Leung, Hannah F. Marshall, Kari C. Nadeau, Suzana Radulovic, Reena Rajcoomar, Mohamed H. Shamji, Sayantani Sindher, Helen A. Brough
The fact that genetic and environmental factors could trigger disruption of the epithelial barrier and subsequently initiate a Th2 inflammatory cascade conversely proposes that protecting the same barrier and promoting adequate interactions with other organs, like the gut, may be crucial for lowering the risk and preventing atopic diseases particularly, food allergies. In this review, we provide an
-
Simplifying asthma management in a university setting: a perspective Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-01-20 Ann C. Bracken, John J. Oppenheimer, Giselle S. Mosnaim, Matthew A. Rank
Abstract not available
-
Association between allergic conditions and COVID-19 susceptibility and outcomes Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-01-17 Chao Chen, Xue Song, Dana J. Murdock, Andrea Marcus, Mohamed Hussein, Jessica J. Jalbert, Gregory P. Geba
Background The relationship between underlying type 2 inflammation and immune response to COVID-19 is unclear. Objective Assessing relationships between allergic conditions and COVID-19 susceptibility and outcomes. Methods In the Optum® database, adult patients with and without major allergic conditions (asthma, atopic dermatitis [AD], allergic rhinitis [AR], food allergy, anaphylaxis, eosinophilic
-
Clinical features of acute spontaneous urticaria in adults Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-01-17 Nizar Abo-Helo, Josef Panasoff, Nili Stein, Shai Cohen
Abstract not available
-
Updates to Penicillin Allergy Delabeling: Reducing the Need for Direct Testing Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-01-12 Jordana F. Brown, Joyce Kim, YoungYoon Ham, Shyam R. Joshi
Abstract not available
-
Patient Partnerships and Minimally Disruptive Medicine Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-01-06 S Shahzad Mustafa, Aikaterini Anagnostou, Matthew Greenhawt, Jay A. Lieberman, Marcus Shaker
Abstract not available
-
Analyzing Co-morbidities and their Influence on Severe Asthma: Another Missing Piece of the Puzzle Solved? Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-01-01 Arjun Mohan, Brinda Desai, Njira Lugogo
Abstract not available
-
Development of the Rapid Cough Questionnaire (RCQ): Key Item Identification Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2023-12-28 Hyeon-Kyoung Koo, Ji-Yong Moon, Jin Woo Kim, Seung Hun Jang, Jae-Woo Kwon, Byung-Jae Lee, Yong Bum Park, Deog Kyeom Kim
Background The Leicester Cough Questionnaire (LCQ) is a reliable tool for measuring the multidimensional impact of cough on patients’ quality of life; however, its scoring algorithm is too lengthy and complex for routine clinical use. Objective This study aimed to develop a simplified version of the LCQ, the Rapid Cough Questionnaire (RCQ), as a substitute in clinical practice and to validate the RCQ
-
Baked Milk and Egg Diets Revisited Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2023-12-26 Julia E.M. Upton, Dennis Wong, Anna Nowak-Wegrzyn
Most milk and egg allergic children are non-reactive to modified forms of milk and egg in bakery products such as muffins due to conformational changes in proteins. These baked milk (BM) and baked egg (BE) diets have become commonplace in the management of milk and egg allergy, respectively. Current laboratory and skin test based diagnostic approaches remain limited in their ability to predict BM/BE
-
Physician adherence to anaphylaxis guidelines among different age groups in emergency departments: 20-year observational study Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2023-12-25 Chia-Hua Ho, Hsin-Ju Lee, Yu-Hsin Yeh, Chun-Chun Gau, Joo-Wei Lim, Yu-Tang Juan, Hsin-Yi Huang, Hui-Ju Tsai, Jing-Long Huang, Tsung-Chieh Yao
Background Anaphylaxis is an acute and serious allergic reaction. Little is known about physician adherence to anaphylaxis guidelines among patients across different age groups. Objective To investigate real-world physician adherence to anaphylaxis guidelines among children, adults, and elders in emergency departments. Methods This study retrospectively analyzed all consecutive patients with anaphylaxis
-
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2023-12-25 Luis Perez-de-Llano, Ghislaine Scelo, G. Walter Canonica, Wenjia Chen, William Henley, Désirée Larenas-Linnemann, Matthesadatw J Peters, Paul E. Pfeffer, Trung N. Tran, Charlotte Suppli Ulrik, Todor A. Popov, Mohsen Sadatsafavi, Mark Hew, Jorge Maspero, Peter G. Gibson, George C. Christoff, J. Mark Fitzgerald, Carlos A. Torres-Duque, Celeste M. Porsbjerg, Nikolaos G. Papadopoulos, David B. Price
Background There is little agreement on clinically useful criteria for identifying real-world responders to biologic treatments for asthma. Objective To investigate the impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in adults with severe asthma. Methods This was a longitudinal, cohort study across 22 countries participating in the International Severe Asthma
-
Lack of health disparities during implementation of hospital-initiated care bundle among hospitalized adults with asthma Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2023-12-25 Mary J. Akel, Carlos A. Camargo, Michimasa Fujiogi, Kohei Hasegawa, Valerie G. Press
Abstract not available
-
Occupational Hops Allergy with non-specific Lipid-Transfer-Protein sensitization: cross-reactivity with food non-specific Lipid-Transfer-Protein Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2023-12-25 Borja Bartolomé-Zavala, Juan Luis Estrada-Rodríguez, Víctor Díaz-Golpe
Abstract not available
-
A novel two-step process for the management of inpatient beta-lactam allergy labels Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2023-12-25 Rajan Ravikumar, Nonie S Arora, Rebecca Hanson, Lauren Barhitte, Jerod Nagel, Samuel L. Aitken, Elizabeth Spranger, Linda Bashaw, Tejal Gandhi, Vincent D. Marshall, Gregory A Eschenauer
Background Inpatient beta-lactam allergy labels may increase the unnecessary use of aztreonam and non-beta-lactam antibiotics, which can then lead to more adverse events and increased health care costs, Objective To assess the impact of a novel two-step process (medication history review followed by risk stratification) on rates of beta-lactam delabeling, aztreonam use, and desensitizations on pediatric
-
Hereditary Alpha Tryptasemia Presenting as Recurrent Chemotherapy Hypersensitivity Reactions Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2023-12-25 Rose Monahan, Emely Alfaro, Hansen Ho, Iris M. Otani, Lulu R. Tsao
Abstract not available